-
Sector Analysis
Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2027
Rheumatoid arthritis (RA) is an autoimmune disease that, due to a complex interplay of environmental, immunological, and genetic factors, causes chronic inflammation and progressive deformity of the joints over time. In 2017, the diagnosed prevalence of RA in the 8MM averaged 0.66% in adults 18 years of age and older and 2.7% in adults aged 60 and older. Early RA typically presents as a bilateral inflammatory joint condition, usually beginning in the smaller joints such as the fingers and toes...
-
Consumer Insights
KOL Perspectives: Treatment strategies for pregnant RA patients
This KOL Insight briefing focuses on KOLs views of Treatment strategies for pregnant RA patients
-
Consumer Insights
KOL Perspectives: Rituximab Use in Lupus
This KOL Insight briefing focuses on KOLs views of Rituximab Use in Lupus
-
Consumer Insights
KOL Perspectives: Upadacitinib for Rheumatoid Arthritis
› This KOL Insight briefing focuses on perceptions of novel upadacitinib data in RA
-
Consumer Insights
KOL Perspectives: BTK Inhibitors in RA
This KOL Insight briefing focuses on KOLs views of BTK Inhibitors in RA
-
Product Insights
Stem Cell Transplantation Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Stem Cell Transplantation Global Clinical Trials Review, H2, 2018" provides an overview of Stem Cell Transplantation clinical trials scenario. This report provides top line data relating to the clinical trials on Stem Cell Transplantation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2018" provides an overview of Systemic Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2018" provides an overview of Systemic Sclerosis (Scleroderma) clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Sclerosis (Scleroderma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Transplant Rejection Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Transplant Rejection Global Clinical Trials Review, H2, 2018" provides an overview of Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Digital Landscape: Psoriatic Arthritis
The Digital Landscape Psoriatic Arthritis report analyzes digital activities undertaken by pharma in support of therapies for active Psoriatic Arthritis (PsA).
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.